Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antidepressive agents AND bipolar disorder AND depressive disorder:

Search results

Items: 1 to 20 of 2996

1.

[Biomarkers for Mood Disorders and a Novel Antidepressant (R)-ketamine].

Hashimoto K.

Brain Nerve. 2017 Oct;69(10):1143-1148. doi: 10.11477/mf.1416200882. Review. Japanese.

PMID:
29042527
2.

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI.

Brain Stimul. 2018 Jan - Feb;11(1):75-84. doi: 10.1016/j.brs.2017.09.010. Epub 2017 Sep 23.

PMID:
29030111
3.

Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder.

Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, Colombo C, Drexhage HA.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e986-e993. doi: 10.4088/JCP.16m11310.

PMID:
28922589
4.

White matter tract integrity is associated with antidepressant response to lurasidone in bipolar depression.

Lan MJ, Rubin-Falcone H, Motiwala F, Chen Y, Stewart JW, Hellerstein DJ, Mann JJ, McGrath PJ.

Bipolar Disord. 2017 Sep;19(6):444-449. doi: 10.1111/bdi.12509. Epub 2017 Aug 10.

PMID:
28796415
5.

Effects of psychopharmacological treatment with antidepressants on the vascular system.

Kahl KG, Westhoff-Bleck M, Krüger THC.

Vascul Pharmacol. 2017 Sep;96-98:11-18. doi: 10.1016/j.vph.2017.07.004. Epub 2017 Jul 25. Review.

PMID:
28754273
6.

A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders.

Wilkinson ST, Toprak M, Turner MS, Levine SP, Katz RB, Sanacora G.

Am J Psychiatry. 2017 Jul 1;174(7):695-696. doi: 10.1176/appi.ajp.2017.17020239. No abstract available.

7.

Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.

Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM; ELECT-TDCS Investigators.

N Engl J Med. 2017 Jun 29;376(26):2523-2533. doi: 10.1056/NEJMoa1612999.

8.

Genetics and pharmacogenetics of mood disorders.

Serretti A.

Psychiatr Pol. 2017 Apr 30;51(2):197-203. doi: 10.12740/PP/68914. Epub 2017 Apr 30. Review. English, Polish.

9.

Ketamine for Depression, 2: Diagnostic and Contextual Indications.

Andrade C.

J Clin Psychiatry. 2017 May;78(5):e555-e558. doi: 10.4088/JCP.17f11629. Review.

10.

Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.

Yang A, Ciolino JD, Pinheiro E, Rasmussen-Torvik LJ, Sit DKY, Wisner KL.

J Clin Psychiatry. 2017 May;78(5):605-611. doi: 10.4088/JCP.16m11044.

PMID:
28570796
11.

Getting Personalized: Brain Scan Biomarkers for Guiding Depression Interventions.

Williams LM.

Am J Psychiatry. 2017 Jun 1;174(6):503-505. doi: 10.1176/appi.ajp.2017.17030314. No abstract available.

PMID:
28565957
12.

Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.

Barbuti M, Pacchiarotti I, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G; BRIDGE-II-Mix Study Group.

J Affect Disord. 2017 Sep;219:187-192. doi: 10.1016/j.jad.2017.05.035. Epub 2017 May 24.

PMID:
28558366
13.

Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.

López-Díaz Á, Fernández-González JL, Luján-Jiménez JE, Galiano-Rus S, Gutiérrez-Rojas L.

Ther Adv Psychopharmacol. 2017 Apr;7(4):137-140. doi: 10.1177/2045125316675578. Epub 2017 Jan 1. Review.

14.

Bipolar postpartum depression: An update and recommendations.

Sharma V, Doobay M, Baczynski C.

J Affect Disord. 2017 Sep;219:105-111. doi: 10.1016/j.jad.2017.05.014. Epub 2017 May 11. Review.

PMID:
28535448
15.

Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study.

Wesseloo R, Liu X, Clark CT, Kushner SA, Munk-Olsen T, Bergink V.

J Affect Disord. 2017 Aug 15;218:394-397. doi: 10.1016/j.jad.2017.04.070. Epub 2017 May 3.

PMID:
28501739
16.

Use of Buprenorphine in treatment of refractory depression-A review of current literature.

Stanciu CN, Glass OM, Penders TM.

Asian J Psychiatr. 2017 Apr;26:94-98. doi: 10.1016/j.ajp.2017.01.015. Epub 2017 Jan 27. Review.

PMID:
28483102
17.

Mixed features in major depressive disorder: diagnoses and treatments.

Suppes T, Ostacher M.

CNS Spectr. 2017 Apr;22(2):155-160. doi: 10.1017/S1092852917000256. Review.

PMID:
28462772
18.

The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects.

McIntyre RS, Johe K, Rong C, Lee Y.

Expert Opin Investig Drugs. 2017 Jun;26(6):767-770. doi: 10.1080/13543784.2017.1324847. Epub 2017 May 8. Review.

PMID:
28460574
19.

Microtubule associated protein 2 in bipolar depression: Impact of pregnenolone.

Daftary S, Yon JM, Choi EK, Kim YB, Bice C, Kulikova A, Park J, Sherwood Brown E.

J Affect Disord. 2017 Aug 15;218:49-52. doi: 10.1016/j.jad.2017.04.024. Epub 2017 Apr 19.

PMID:
28458115
20.

Guidelines for the recognition and management of mixed depression.

Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, Thase ME, Vieta E, Young A, Zimmerman M, McIntyre RS.

CNS Spectr. 2017 Apr;22(2):203-219. doi: 10.1017/S1092852917000165. Epub 2017 Feb 28. Review.

PMID:
28421980

Supplemental Content

Loading ...
Support Center